Morgan Stanley on Moderna (MRNA) Annoucement: 'Respiratory pipeline expansion inline with strategy'
Tweet Send to a Friend
Morgan Stanley analyst Matthew Harrison reiterated an Equalweight rating and $205.00 price target on Moderna (NASDAQ: MRNA)The analyst comments "Moderna ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
